Torsten Greif

Torsten Greif is an accomplished business leader with extensive experience across various industries, primarily focusing on pharmaceuticals, renewable energy, and real estate. Since May 2019, Torsten Greif has served as the Geschäftsführer and Gesellschafter at Four 20 Pharma GmbH, establishing a gold standard for medical cannabis in Germany. In additional roles, Torsten Greif is a Gesellschafter and CSO at Energieplan Ost West GmbH & Co. KG, overseeing projects in wind energy, and maintains ownership in GREIF Beteiligungen, GREIF HOLLANDER Gruppe, and GREIF Consulting & Services. Previous positions include Executive Business Development Manager at ROLAND Schutzbrief and Senior roles at Deloitte Deutschland, showcasing a strong background in business development and consulting. Torsten Greif holds an MBA from Maastricht School of Management and a BBA from Northwood University.